Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation

J G Mainz1, J Hentschel, C Schien

  • 1CF Centre, Pediatric Pneumology, Jena University Hospital, Germany. Jochen.Mainz@med.uni-jena.de

Abstract

Insights

Pseudomonas aeruginosa in the upper airways of cystic fibrosis patients can colonize transplanted lungs. Regular sinonasal assessment and antimicrobial inhalation are recommended post-lung transplantation to prevent graft dysfunction.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Cystic Fibrosis (CF) patients often suffer from Pseudomonas aeruginosa infections.
  • Lung transplantation (LTX) is a life-saving procedure for advanced CF.
  • Pre-existing P. aeruginosa colonization poses a risk for LTX recipients.

Observation:

  • Two CF patients undergoing LTX for P. aeruginosa-related lung destruction were studied.
  • Patient 1 experienced donor lung colonization with P. aeruginosa from pre-transplant isolates.
  • Patient 2 remained P. aeruginosa-free in lower airways post-LTX, despite persistent upper airway colonization.

Findings:

  • Identical P. aeruginosa genotypes were found in pre- and post-LTX upper airway samples (nasal lavages, throat swabs) in both patients.
  • Upper airways act as a reservoir for P. aeruginosa, increasing the risk of donor lung colonization.
  • Patient 2's regimen included sinonasal Colomycin inhalation, potentially preventing lower airway re-colonization.

Implications:

  • Regular sinonasal P. aeruginosa screening is crucial before and after LTX.
  • The upper airway reservoir highlights the need for targeted antimicrobial strategies.
  • Investigating sinonasal antimicrobial inhalation may reduce P. aeruginosa-related graft dysfunction post-LTX.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...